Search Results - "González Lama, Y."

Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients by González‐Lama, Y., Bermejo, F., López‐Sanromán, A., García‐Sánchez, V., Esteve, M., Cabriada, J. L., McNicholl, A. G., Pajares, R., Casellas, F., Merino, O., Carpio, D., Vera, M. I., Muñoz, C., Calvo, M., Benito, L. M., Bujanda, L., García‐Fernández, F. J., Ricart, E., Ginard, D., Velasco, M., Carneros, J. A., Manceñido, N., Calvo, M., Algaba, A., Froilan, C., Cara, C., Maté, J., Abreu, L., Gisbert, J. P.

“…Aliment Pharmacol Ther 2011; 34: 544–554 Summary Background  Low thiopurine‐methyl‐transferase (TPMT) activity and high 6‐thioguanine‐nucleotide (6TGN)…”
Get full text

Letter: metabolite monitoring for thiopurines in Crohn's disease – still not fully understood by González Lama, Y., Gisbert, J. P.

Get full text

Letter: TPMT - not all that glitters is gold by González-Lama, Y., Gisbert, J. P.

Get full text

Why thiopurine metabolites are relevant: authors' reply by González-Lama, Y., Gisbert, J. P.

Get full text

Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease: authors’ reply by González‐Lama, Y., Gisbert, J. P.

Get full text

Thiopurine metabolite measurement – not for everyone: authors’ reply by González‐Lama, Y., Gisbert, J. P.

Get full text

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy by Hedin, C R H, Vavricka, S R, Stagg, A J, Schoepfer, A, Raine, T, Puig, L, Pleyer, U, Navarini, A, van der Meulen-de Jong, A E, Maul, J, Katsanos, K, Kagramanova, A, Greuter, T, González-Lama, Y, van Gaalen, F, Ellul, P, Burisch, J, Bettenworth, D, Becker, M D, Bamias, G, Rieder, F

“…Abstract This article reports on the sixth scientific workshop of the European Crohn’s and Colitis Organisation [ECCO] on the pathogenesis of extraintestinal…”
Get full text

Systematic review: infliximab therapy in ulcerative colitis by GISBERT, J. P., GONZÁLEZ‐LAMA, Y., MATÉ, J.

“…Summary Aim To perform a systematic review and meta‐analysis on the efficacy and tolerance of infliximab in ulcerative colitis. Methods Selection of studies:…”
Get full text

Selective biliary cannulation using pancreatic guide-wire placement: further evidence needed to support the use of an already known technique by González Lama, Y, Abreu, L, Calleja, J L, Vera, M I, Garrido, A, Escartín, P

Get more information

P1023 Variability in Mesalazine Management for Ulcerative Proctitis Include Doses, Route of Administration and Use of Fecal Calprotectin: Insights from Clinical Practice Across Spain Beyond Clinical Guidelines by Bastida Paz, G, Ceballos, D, Ricart, E, Marín-Jiménez, I, Menchén, L, Carpio, D, Ginard, D, Muñoz, F, González-Lama, Y

Get full text

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study by Casanova, M J, Chaparro, M, García-Sánchez, V, Nantes, O, Leo, E, Rojas-Feria, M, Jauregui-Amezaga, A, García-López, S, Huguet, J M, Arguelles-Arias, F, Aicart, M, Marín-Jiménez, I, Gómez-García, M, Muñoz, F, Esteve, M, Bujanda, L, Cortés, X, Tosca, J, Pineda, J R, Mañosa, M, Llaó, J, Guardiola, J, Pérez-Martínez, I, Muñoz, C, González-Lama, Y, Hinojosa, J, Vázquez, J M, Martinez-Montiel, M P, Rodríguez, G E, Pajares, R, García-Sepulcre, M F, Hernández-Martínez, A, Pérez-Calle, J L, Beltrán, B, Busquets, D, Ramos, L, Bermejo, F, Barrio, J, Barreiro-de Acosta, M, Roncedo, O, Calvet, X, Hervías, D, Gomollón, F, Domínguez-Antonaya, M, Alcaín, G, Sicilia, B, Dueñas, C, Gutiérrez, A, Lorente-Poyatos, R, Domínguez, M, Khorrami, S, Muñoz, C, Taxonera, C, Rodríguez-Pérez, A, Ponferrada, A, Van Domselaar, M, Arias-Rivera, M L, Merino, O, Castro, E, Marrero, J M, Martín-Arranz, M, Botella, B, Fernández-Salazar, L, Monfort, D, Opio, V, García-Herola, A, Menacho, M, Ramírez-de la Piscina, P, Ceballos, D, Almela, P, Navarro-Llavat, M, Robles-Alonso, V, Vega-López, A B, Moraleja, I, Novella, M T, Castaño-Milla, C, Sánchez-Torres, A, Benítez, J M, Rodríguez, C, Castro, L, Garrido, E, Domènech, E, García-Planella, E, Gisbert, J P

“…The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory…”
Get full text

Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease: authors’ reply: Letters to the Editors by González-Lama, Y., Gisbert, J. P.

Get full text

Thiopurine metabolite measurement - not for everyone: authors’ reply: Letters to the Editors by González-Lama, Y., Gisbert, J. P.

Get full text

DOP60 Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER Study by Gutiérrez Casbas, A, Rodríguez-Lago, I, Marín-Jiménez, I, Plaza, Z, Gratacós, J, Trujillo, E, Pérez-Pampín, E, Barreiro de Acosta, M, Aznar-Esquivel, A, Carrillo, M, García-Vivar, M L, Muñoz-Villafranca, M D C, Ladehesa, L, Iglesias-Flores, E, Merino, C, González-Lama, Y, Arévalo, M, Calvet, X, Brandy-García, A, Izquierdo-Romero, M, Manrique, S, Olmedo, R, García-LLorente, J F, Zugaza, J, Ros-Vilamajo, I, Rull, N, Pinto-Tasende, J A, Ucha, P, González, C, Rodríguez-Martín, F, Serrano, S, Domínguez-Alvaro, M, Prado-Galbarro, F J, Sanz, J

Get full text

Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis by Bassas-Vila, J, González Lama, Y

“…The first description of perianal fistulas and complications in Crohn disease was made 75 years ago by Penner and Crohn. Published studies have subsequently…”
Get full text

Clinical features of hidradenitis suppurativa and Crohn disease: what do these two entities have in common? by Vilarrasa Rull, E, González Lama, Y

“…Hidradenitis suppurativa (HS) and Crohn disease (CD) are chronic, recurrent inflammatory diseases. They share certain clinical characteristics and flares are…”
Get full text

Therapeutic approach to Crohn disease: possible parallels with hidradenitis suppurativa by González Lama, Y, Marín-Jiménez, I

“…The current controversy in the setting of dermatology surrounding the treatment of inflammatory diseases, and specifically hidradenitis suppurativa, bears…”
Get full text

P214 How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee by Casellas, F, Ginard, D, García-López, S, González-Lama, Y, Arguelles-Arias, F, Barreiro-de Acosta, M, Marín Sánchez, L, Mendive, J M, Saldaña, R

“…Abstract Background To provide a patient-centred care in ulcerative colitis (UC), it is essential to address and to incorporate patient’s opinions,…”
Get full text

P120 Usefulness of the faecal calprotectin for the diagnosis of inflammatory bowel disease in patients with spondylorarthritis and no digestive symptoms by González-Lama, Y, Matallana, V, Calvo, M, Espinosa, M, Ramos, C, Merino, C, Ruiz-Antorán, B, González-Partida, I, Vera, M I, Sanz, J

“…Abstract Background Faecal calprotectin (FC) is a biomarker of bowel inflammation widely spread in diagnosis and follow-up of inflammatory bowel disease (IBD)…”
Get full text

Consenso Delphi sobre Estrategias Terapéuticas y de Prevención Sanitaria de la hipovitaminosis D by Aguilar-del Rey, J, Jódar-Gimeno, E, Brañas, F, Gómez-Alonso, C, González-Lama, Y, Malouf-Sierra, J, Sánchez-Borrego, R, Segura-de la Morena, J, Suárez-Pérez, JA, Valdés y Llorca, C

Get full text